Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Immucor Accepts $2 Billion Private Equity Buyout, But Open To Richer Offer

This article was originally published in The Gray Sheet

Executive Summary

Blood transfusion testing product maker Immucor will gain added financial resources for future growth following investment firm TPG Capital’s purchase of the company for $1.97 billion, the firm announced July 5.
Advertisement

Related Content

People In Brief
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2011
Kinetic Concepts To Go Private Via $6.3 Billion Buyout
Kinetic Concepts To Go Private Via $6.3 Billion Buyout
People In Brief
Immucor builds blood transfusion portfolio
Diagnostics In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

MT030323

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel